Children
(Mar 2022)
Daptomycin for Treatment of <i>S. Epidermidis</i> Endocarditis in an Extremely Preterm Neonate—Outcome and Perspectives
Chiara Minotti,
Ilaria Zuccon,
Elena Priante,
Luca Bonadies,
Costanza Di Chiara,
Daniele Donà,
Eugenio Baraldi,
Paola Costenaro
Affiliations
Chiara Minotti
Department of Women’s and Children’s Health, University of Padua, Via Giustiniani 2, 35128 Padua, Italy
Ilaria Zuccon
Department of Women’s and Children’s Health, University of Padua, Via Giustiniani 2, 35128 Padua, Italy
Elena Priante
Neonatal Intensive Care Unit, Department of Women’s and Children’s Health, University Hospital of Padua, Via Giustiniani 2, 35128 Padua, Italy
Luca Bonadies
Neonatal Intensive Care Unit, Department of Women’s and Children’s Health, University Hospital of Padua, Via Giustiniani 2, 35128 Padua, Italy
Costanza Di Chiara
Department of Women’s and Children’s Health, University of Padua, Via Giustiniani 2, 35128 Padua, Italy
Daniele Donà
Division of Pediatric Infectious Diseases, Department of Women’s and Children’s Health, University of Padua, Via Giustiniani 2, 35128 Padua, Italy
Eugenio Baraldi
Neonatal Intensive Care Unit, Department of Women’s and Children’s Health, University Hospital of Padua, Via Giustiniani 2, 35128 Padua, Italy
Paola Costenaro
Division of Pediatric Infectious Diseases, Department of Women’s and Children’s Health, University of Padua, Via Giustiniani 2, 35128 Padua, Italy
DOI
https://doi.org/10.3390/children9040457
Journal volume & issue
Vol. 9,
no. 4
Abstract
Read online
With a considerable morbidity and mortality burden, infective endocarditis still represents a challenge for clinicians. This is a case of persistent Staphylococcus epidermidis endocarditis in an extremely preterm newborn. The infection, initially treated with vancomycin, was successfully cured with daptomycin. Its use was safe and effective, ensuring a complete remission without adverse effects.
Keywords
WeChat QR code
Close
